LAM is a cystic lung disorder that involves the loss of function of the tuberous sclerosis complex 1 or 2 genes (TSC1 and TSC2) which are well-known suppressors of the mTOR pathway23–25. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.